GlassScriptPhysician profile
Timothy E Phelan
NPI 1760543375
$4,222.83
in general payments reported to CMS, 2019-2025
20 companies · $536 in 2025
The $536 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $75.51 · 2021: $114 · 2022: $83.95 · 2023: $1,196 · 2024: $2,031 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,663 · Education: $1,085 · Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,663.49 |
| Education | $1,084.99 |
| Food and Beverage | $1,013.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,296.56 | 2023-2025 | |
| Coloplast Corp | $850.08 | 2023 | Altis |
| Abbvie INC. | $194.17 | 2019-2024 | |
| Astellas Pharma US INC | $126.37 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $114.64 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $93.94 | 2023-2025 | |
| Coopersurgical, INC. | $92.93 | 2019-2023 | Endosee |
| Pfizer INC. | $90.98 | 2023-2024 | |
| Sage Therapeutics, LLC | $58.72 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $55.23 | 2019-2020 | |
| Organon LLC | $54.27 | 2023-2025 | Nuvaring, Nexplanon |
| Sumitomo Pharma America, INC. | $35.41 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $30.51 | 2019 | |
| Hologic Sales and Service, LLC | $25.56 | 2019 | |
| Supernus Pharmaceuticals, INC. | $22.20 | 2025 | Qelbree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $20.22 | 2025 | Fornisee |
| E.R. Squibb & Sons, L.L.C. | $18.79 | 2023 | Camzyos |
| Merck Sharp & Dohme LLC | $16.89 | 2019 | |
| Mission Pharmacal Company | $13.67 | 2019 | |
| Allergan, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Phelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.